2024 Annual General Meeting - Key Dates
Released
Released
Announcement PDF
Delivering & developing new treatments for mental
health & neurological conditions
ASX Announcement | 16 Sept 2024
2024 ANNUAL GENERAL MEETING – KEY DATES
Emyria Limited (ASX: EMD) (“Emyria”, or the “Company”) developing and delivering new
treatments for mental health and select neurological conditions, is pleased to announce the
2024 annual general meeting has been scheduled for 11.00am (WST) on Tuesday, 12
November 2024 at the offices of Stantons International at Level 2, 40 Kings Park Road, West
Perth, Western Australia.
An item of business at the AGM will be the re-election of directors. The closing date for the
receipt of director nominations is Tuesday, 24 September 2024.
Nominations must be received at the Company’s registered office no later than 5.00pm (WST)
on Tuesday, 24 September 2024.
This announcement was authorised for release to the ASX by the Board of Emyria Limited.
For further information, investment opportunities, or more about our approach to
mental health treatment, please contact:
Managing Director
Michael Winlo
+61 (0) 8 6559 2800
mwinlo@emyria.com
Emyria ASX Announcement | 16 Sep 2024
Media Contact
Haley Chartres
+61 (0) 423 139 163
haley@hck.digital
Corporate Advisor
Sufian Ahmed
+61 (0) 412 316 162
info@62capital.com.au
1
Share your feedback
Discover